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Abstract: The biological effects and cellular activations triggered by monosodium urate (MSU) and
calcium pyrophosphate dihydrate (monoclinic: m-CPPD) crystals might be modulated by protein
coating on the crystal surface. This study is aimed at: (i) Identifying proteins adsorbed on m-CPPD
crystals, and the underlying mechanisms of protein adsorption, and (ii) to understand how protein
coating did modulate the inflammatory properties of m-CPPD crystals. The effects of protein coating
were assessed in vitro using primary macrophages and THP1 monocytes. Physico-chemical studies on
the adsorption of bovine serum albumin (BSA) upon m-CPPD crystals were performed. Adsorption of
serum proteins, and BSA on MSU, as well as upon m-CPPD crystals, inhibited their capacity to induce
interleukin-1-β secretions, along with a decreased ATP secretion, and a disturbance of mitochondrial
membrane depolarization, suggesting an alteration of NLRP3 inflammasome activation. Proteomic
analysis identified numerous m-CPPD-associated proteins including hemoglobin, complement,
albumin, apolipoproteins and coagulation factors. BSA adsorption on m-CPPD crystals followed
a Langmuir-Freundlich isotherm, suggesting that it could modulate m-CPPD crystal-induced cell
responses through crystal/cell-membrane interaction. BSA is adsorbed on m-CPPD crystals with
weak interactions, confirmed by the preliminary AFM study, but strong interactions of BSA molecules
with each other occurred favoring crystal agglomeration, which might contribute to a decrease
in the inflammatory properties of m-CPPD crystals. These findings give new insights into the
pathogenesis of crystal-related rheumatic diseases and subsequently may open the way for new
therapeutic approaches.
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1. Introduction
Calcium orthophosphates such as carbonated-apatites, calcium pyrophosphate dihydrate (CPPD)
and monosodium urate (MSU) are three main types of crystals associated with rheumatic diseases,
responsible for hydroxyapatite rheumatism, CPP deposition disease and gout, respectively.
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Prevalence of these crystal depositions is high, occurring for example in more than 17.5% of people
over 75 years for CPPD crystals, and between 0.9 and more than 10% for MSU crystals [1–3]. Monoclinic
and triclinic CPPD phases (m-CPPD and t-CPPD respectively) are the two CPPD crystals identified
in human tissues, while the existence of precursor forms such as monoclinic calcium pyrophosphate
tetrahydrate beta (m-CPPTβ), and amorphous calcium pyrophosphate (a-CPP) phases have been
suggested by in vitro studies [4–6]. Although these crystals remain mostly asymptomatic, they can
induce recurrent, self-resolving and interleukin (IL)-1β-driven inflammation reactions [7–9]. How these
crystals can switch from an asymptomatic state to an inflammatory one is still unknown. Similarly, how
the crystal-induced inflammation self-resolves remains not completely understood. We speculated
that modification of protein coating on the crystal surface might modulate immune cell responses and
contribute to these different clinical phenotypes.
Studies show that apatite, MSU and CPPD crystals harbor different inflammatory potentials,
which can rely on their physico-chemical characteristics, including chemical composition, crystal
shape, size and surface properties [10–18]. Recently, we confirm that among CPPD crystals, m-CPPD
crystals are the most inflammatory ones, while the amorphous phases do not have inflammatory
property [14,17,19]. The inflammatory potential of CPPD crystals depends on their capacity to
activate MAPK pathways and the nuclear factor Kappa B (NF-κB) [17]. Lebre et al. observe that the
inflammatory potential of hydroxyapatite particles varies with their sizes and shapes [10]. Thus, small
needle-shaped particles induce a higher IL-1β secretion and neutrophils recruitment than smooth,
spherical particles of comparable size, or than larger particles [10]. These results suggest that the clinical
features might be secondary to the presence of different types of crystals which might modify during
time. Thus, Swan et al. observe that the ratio of m-CPPD/t-CPPD crystals is higher in inflammatory
synovial fluids than in non-inflammatory synovial fluids [20]. We hypothesized that CPPD crystal
phases exhibited different protein adsorption properties which might explain their capacity to activate
immune cells.
Thus, the inflammatory potential of different crystals also depends on their surface properties
that can modulate crystal/cell interactions either through their surface charge and/or through proteins
coated on their surface. MSU crystal surfaces can be coated by several proteins, including albumin,
fibrinogen, fibronectin, lysozyme, bovine serum albumin (BSA), ovalbumin, immunoglobulin (Ig),
apolipoproteins (Apo) and high and low density lipoproteins (HDL and LDL) [21–25]. MSU crystal
inflammatory properties vary according to proteins adsorbed on their surface. Thus, adsorption of
ApoA, ApoE, human serum or HDL inhibits MSU crystal-induced inflammation, while IgG coating
enhances it [23–29]. Moreover, proteins coated on MSU crystals change during inflammation phases,
and might contribute to the self-limiting nature of gout flare [27]. Similarly, nanoparticles (NP) are
rapidly coated with proteins, resulting in the formation of the so-called protein corona. The adsorbed
proteins modulate NP interactions with the innate immune system, and depending on coated-proteins
innate immune cell responses can have opposing effects, with either a suppression or a stimulation
effect [30,31]. Contrary to MSU crystals and NP, the effect of protein coating on CPPD crystal-induced
inflammation, described 30 to 40 years ago, is scarcely investigated, and using mostly t-CPPD crystals,
which are less inflammatory than m-CPPD crystals [13,17,21,22,32,33]. Moreover, none of these studies
have assessed the effects of protein coating on IL-1β production, which is the main inflammatory
cytokine involved in crystal-induced inflammation. We aimed to assess the effects of protein coating on
CPPD crystal-induced inflammation, to identify proteins adsorbed on CPPD crystals using proteomic
technology, and to study the mechanisms involved in these interactions.
Indeed, how proteins adsorb onto crystal surfaces remains unclear. Protein adsorption could
be related to either a charge-mediated process or a surface-ion-exchange process, as described with
calcium orthophosphate crystals [34–36]. Both MSU and CPPD crystals have a negative zeta potential,
and could interact with positively charged proteins. However, this hypothesis needs to be evaluated,
and the mechanism of protein adsorption onto CPPD crystals thoroughly studied.
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2. Results
2.1. Adsorption of Serum Proteins Inhibits Crystal-Induced Inflammation
We first assessed the effect of MSU and m-CPPD crystals which were pre-incubated with fetal
bovine serum (FBS) on IL-1β secretion by the human cell line THP1. We observed that both FBS-coated
MSU and m-CPPD crystals were less inflammatory than naked MSU and m-CPPD crystals (Figure 1).
Thus, FBS coating decreased by more than 75% and 90% IL-1β production induced by naked m-CPPD
and MSU crystals, respectively. Interestingly, FBS coating did not modulate MSU and m-CPPD
crystal-induced IL-1β production when using mouse bone marrow derived macrophages (BMDM)
suggesting specie specificity. Indeed, when we pre-incubated MSU and m-CPPD crystals with mouse
serum or mouse blood lysate, IL-1β production was dramatically decreased compared to naked crystals
(Figure 1B). Next, we wondered whether FBS coating could modulate the effects of MSU and m-CPPD
crystals on other inflammatory cytokines in THP1. Our results showed that pre-incubation of m-CPPD
and MSU crystals in FBS inhibited their capacity to induce the expression of IL-1β, TNF-α, IL-8 and
cyclooxygenase (Cox)-2 genes (Figure 1C).J. Funct. Biomater. 2019, 10, 18 4 of 21 
 
 
Figure 1. Adsorption of serum proteins inhibits crystal-induced inflammation. THP-1 or mouse 
BMDMs were primed the day before the experiment. After 6 h of crystal stimulation, supernatants 
and total RNA were collected. (A) Human IL-1β concentrations from THP-1 cultures (n = 6) were 
quantified by ELISA. (B) Mouse IL-1β concentrations from BMDM cultures (n = 6) were quantified by 
ELISA. (C) IL-1β, IL-8, TNF-α and Cox-2 gene expression from THP-1 cells were quantified by RT-
qPCR (n = 4). Multiple t-test with FDR correction between uncoated and FBS-coated crystals were 
performed: *p < 0.05; **p < 0.01; ***p < 0.001. 
2.2. Proteomic analysis of proteins adsorbed on m-CPPD crystals 
To determine which of the FBS proteins are associated with the inhibition of the inflammatory 
response induced by m-CPPD crystals we performed proteomic analysis of the proteins adsorbed on 
m-CPPD crystals after 30 min of incubation in FBS at 37 °C. Proteomic analysis identified 30 proteins 
with a mascot score higher than 40 (Table 1). Among these proteins 10 had a mascot score higher than 
Figure 1. Adsorption of serum proteins inhibits crystal-induced inflammation. THP-1 or mouse
BMDMs were primed the day b fore th experim t. After 6 h of crystal stimulatio , supernatants
and total RNA were collected. (A) Human IL-1β concentrations from THP-1 cultures (n = 6) were
quantified by ELISA. (B) Mouse IL-1β concentrations from BMDM cultures (n = 6) were quantified
by ELISA. (C) IL-1β, IL-8, TNF α and Cox-2 gene expression from THP-1 cell wer quantified by
RT-qPCR (n = 4). Multiple t-test with FDR correction between uncoated and FBS-coated crystals were
performed: * p < 0.05; ** p < 0.01; *** p < 0.001.
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2.2. Proteomic Analysis of Proteins Adsorbed on m-CPPD Crystals
To determine which of the FBS proteins are associated with the inhibition of the inflammatory
response induced by m-CPPD crystals we performed proteomic analysis of the proteins adsorbed on
m-CPPD crystals after 30 min of incubation in FBS at 37 ◦C. Proteomic analysis identified 30 proteins
with a mascot score higher than 40 (Table 1). Among these proteins 10 had a mascot score higher than
100 and were identified as fetal hemoglobin subunit alpha and beta, fibrinogen, alpha-trypsin inhibitor
heavy chain H4, alpha-2-HS glycoprotein precursor, albumin, complement C4 precursor and Apo
A-1 and A-2 precursors. Interestingly, most of these proteins had been previously identified on MSU
crystals [23,27,29] except for albumin which had little affinity to bind MSU crystals [22].
Table 1. List of the proteins with a mascot score higher than 40 identified on m-CPPD crystal surfaces
after their incubation in FBS during 30 min at 37 ◦C.
Accession Description Σ Coverage Mascot Score
62460494 hemoglobin fetal subunit beta [Bos taurus] 64.83 424.4
148745450 Fibrinogen alpha chain [Bos taurus] 32.85 312.2
116812902 hemoglobin subunit alpha [Bos taurus] 99.30 308.2
296474801 TPA: inter-alpha-trypsin inhibitor heavy chain H4precursor [Bos taurus] 8.19 270.7
27806751 alpha-2-HS-glycoprotein precursor [Bos taurus] 21.73 225.2
74267962 ALB protein [Bos taurus] 16.14 185.5
1351907 Serum albumin Precursor 16.14 178.2
114052298 apolipoprotein A-II precursor [Bos taurus] 49.00 140.0
262050656 complement C4 precursor [Bos taurus] 3.96 138.4
75832056 apolipoprotein A-I preproprotein [Bos taurus] 58.11 137.5
268607679 coagulation factor XIII A chain [Bos taurus] 10.52 97.8
27819608 hemoglobin subunit beta [Bos taurus] 41.38 92.0
2501351 Serotransferrin Precursor 6.11 88.8
27806789 transthyretin precursor [Bos taurus] 40.82 82.8
47564119 apolipoprotein C-III precursor [Bos taurus] 44.79 82.0
51592135 cofilin-1 [Sus scrofa] 12.05 81.4
77735583 adenosylhomocysteinase [Bos taurus] 4.17 62.7
156139070 apolipoprotein C-II precursor [Bos taurus] 39.60 57.8
27806487 pigment epithelium-derived factor precursor [Bos taurus] 13.46 57.3
27807209 alpha-2-antiplasmin precursor [Bos taurus] 6.10 54.9
297488254 PREDICTED: serpin A3-3 [Bos taurus] 8.47 54.1
296487363 TPA: myosin, heavy chain 9, non-muscle [Bos taurus] 3.10 52.8
27807167 peroxiredoxin-6 [Bos taurus] 10.27 52.4
27807125 thymosin beta-10 [Bos taurus] 42.86 49.1
297466391 PREDICTED: alpha-2-macroglobulin, partial [Bos taurus] 1.90 47.2
296479148 TPA: alpha-enolase [Bos taurus] 13.82 43.5
114053019 alpha-1B-glycoprotein precursor [Bos taurus] 5.17 41.2
123959760 ubiquitin-like protein 4B [Bos taurus] 5.45 41.2
135806 Prothrombin Precursor 11.20 41.0
2.3. Albumin Coating Inhibits m-CPPD Induced Inflammation
As albumin is the most abundant protein in serum and was identified with high mascot score in
the proteomic analysis, we hypothesized that BSA coating on MSU and m-CPPD crystals contributed
to the reduction of inflammation after FBS pre-incubation. To address this question, we stimulated
THP1 cells with MSU and m-CPPD crystals which were pre-incubated with BSA. Then, we observed
that actually pre-incubation of m-CPPD and MSU crystals with BSA 35% inhibited their capacity to
induce IL-1β production (Figure 2). Similarly, the induction of IL-1β, IL-8 and Cox-2 gene expression
by BSA-coated MSU and m-CPPD crystals was less important than the induction generated by naked
MSU and m-CPPD crystals (Figure 2B). Interestingly, BSA coating did not modulate the effects of MSU
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and m-CPPD crystals on TNF-α gene expression suggesting that protein coating on crystal surface
altered specific intracellular pathways.
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Human IL-1β concentrations were quantified by ELISA in the supernatants (n = 3). (B) mRNA 
quantification of IL-1β, IL-8, TNF-α and Cox-2 gene expression was performed by RT-qPCR (n = 3). 
Multiple t-test with FDR correction between uncoated and crystals pre-incubated with BSA 35% (*): 
*p < 0.05; **p < 0.01; ***p < 0.001. 
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especially how did BSA-coating inhibit m-CPPD induced IL-1β production. IL-1β production is a 
two-step process encompassing the production of pro-IL-1β through NF-κB activation and the 
maturation of pro-IL-1β through NLRP3 inflammasome activation and caspase-1 cleavage [8,17]. We 
first observed that m-CPPD and MSU crystals stimulated strong increase of ATP secretion by THP1 
cells and depolarization of mitochondrial membrane potential, two well-described mechanisms of 
NLRP3 inflammasome activation (Figure 3A) [37,38]. Mitochondrial transmembrane depolarization 
was evidenced by the decrease of JC-1 red/green fluorescence intensity ratio under MSU and m-CPPD 
Figure 2. BSA-coated crystals inhibit crystal induced inflammation. THP-1 cells were primed the
day before experiment. After 6 h of crystal stimulation, supernatants and total RNA were collected.
(A) Human IL-1β concentrations were quantified by ELISA in the supernatants (n = 3). (B) mRNA
quantification of IL-1β, IL-8, TNF-α and Cox-2 gene expression was performed by RT-qPCR (n = 3).
Multiple t-test with FDR correction between uncoated and crystals pre-incubated with BSA 35% (*):
* p < 0.05; ** p < 0.01; *** p < 0.001.
2.4. Protein Adsorption Inhibits Crystal-Induced Inflammation through Inhibition of Membrane-Crystal
Interaction
Then, we investigated how did protein adsorption suppress m-CPPD-induced inflammation,
especially how did BSA-coating inhibit m-CPPD induced IL-1β production. IL-1β production is
a two-step process encompassing the production of pro-IL-1β through NF-κB activation and the
maturation of pro-IL-1β through NLRP3 inflammasome activation and caspase-1 cleavage [8,17].
We first observed that m-CPPD and MSU crystals stimulated strong increase of ATP secretion by THP1
cells and depolarization of mitochondrial membrane potential, two well-described mechanisms of
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NLRP3 inflammasome activation (Figure 3A) [37,38]. Mitochondrial transmembrane depolarization
was evidenced by the decrease of JC-1 red/green fluorescence intensity ratio under MSU and m-CPPD
crystal stimulation. JC-1 (5,5’,6,-’, tetrachloro-1,1’,3,3’ tetraethylbenzimi-dazolylcarbocyanide iodide)
dye formed in mitochondrial with high transmembrane potential j-aggregate complexes that exhibited
high red fluorescence while in mitochondrial with low transmembrane potential it remained in
the monomeric forms with green fluorescence. Consequently, mitochondrial depolarization was
indicated by a decrease in red/green fluorescence intensity ratio [39]. In this experiment, we used
rotenone, an inhibitor of mitochondrial electron transport chain complex I, as positive control to induce
mitochondrial transmembrane depolarization. Figure 3A showed that m-CPPD crystals decreased
JC-1 red/green fluorescence ratio at the same level than rotenone treatment. Next, we showed that
both FBS and BSA pre-incubation significantly inhibited m-CPPD crystal-induced ATP production
and depolarization of mitochondrial membrane potential (Figure 3A,B). Interestingly FBS or BSA
coating did not alter MSU crystal-induced ATP production while it did abrogate MSU crystal-induced
depolarization of mitochondrial membrane potential (Figure 3A,B). These results suggested that
m-CPPD and MSU crystals induced cell activation through different signaling pathways. As MSU
crystal-activated NLRP3 inflammasome involves crystal/membrane interactions, we assessed whether
the inhibitory effect of FBS coating on m-CPPD crystals was secondary to these interactions [40–42].
To address this question, we let uncoated m-CPPD crystals interact with cells during 15 min and
then added in the culture medium 10% of FBS. By doing this, we observed that adding FBS in the
culture medium after cell stimulation with uncoated m-CPPD crystals did not modify the amount of
IL-1β production induced by naked m-CPPD crystals (Figure 3C). In contrary, the amount of IL-1β
was very low if cells were stimulated with uncoated m-CPPD crystals in medium containing FBS or
with FBS-coated m-CPPD crystals (Figure 3C). Altogether these results suggested that adsorption
of serum proteins on m-CPPD crystals modulates their cellular effects through disturbances of
crystal-membrane interactions.
J. Funct. Biomater. 2019, 10, 18 7 of 19
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mitochondrial transmembrane depolarization. Kruskal-Wallis test with FDR correction compare to 
Ctrl (*) or uncoated crystals (#): *p < 0.05; #p < 0.05. (C) Cells were stimulated with (i) uncoated m-
CPPD crystals in either serum-free medium or serum-containing medium; (ii) with FBS-coated m-
CPPD crystals in serum-free medium or iii) with uncoated m-CPPD crystals during 15 min in serum-
free medium and then FBS was added in the culture medium. Supernatants were collected after 6 h 
of stimulation and human IL-1β (n = 3) concentrations were quantified by ELISA. Multiple t-test with 
FDR correction between uncoated and FBS coated crystals (*). 
2.5. Physico-chemical study of the adsorption of BSA on m-CPPD crystals and its model of adsorption 
To understand the mechanism of adsorption of protein on m-CPPD crystals, we studied the 
adsorption of BSA as a protein model on m-CPPD synthetic crystals in aqueous medium (NaCl 0.15 
M) with different concentrations of BSA at 37 °C and pH 7.4. In a first approach, the adsorption kinetic 
of BSA on m-CPPD crystals was plotted by following the evolution of BSA quantity adsorbed (Qads) 
Figure 3. Adsorption of serum proteins on m-CPPD crystals modulates extracellular ATP production
and mitochondrial membrane potential. THP-1 cells were primed the day before the experiment. (A)
After 2 h of crystal stimulation, supernatants were collected and ATP concentrations were quantified
(n = 3). (B) After 30 min of crystal stimulation, cells were incubated with the JC-1 probe and then
analyzed by flow cytometry (n = 3). The decrease of red/green fluorescence intensity ratio indicated
mitochondrial transmembrane depolarization. Kruskal-Wallis test with FDR correction compare to Ctrl
(*) or uncoated crystals (#): * p < 0.05; # p < 0.05. (C) Cells were stimulated with (i) uncoated m-CPPD
crystals in either serum-free medium or serum-containing medium; (ii) with FBS-coated m-CPPD
crystals in serum-free medium or iii) with uncoated m-CPPD crystals during 15 min in serum-free
medium and then FBS was added in the culture medium. Supernatants were collected after 6 h of
stimulation and human IL-1β (n = 3) concentrations were quantified by ELISA. Multiple t-test with
FDR correction between uncoated and FBS coated crystals (*).
2.5. Physico-Chemical Study of the Adsorption of BSA on m-CPPD Crystals and Its Model of Adsorption
To understand the mechanism of adsorption of protein on m-CPPD crystals, we studied the
adsorption of BSA as a prot in model n m-CPPD synthetic crystals in aqueous medium (NaCl 0.15 M)
with different concentr tions of BSA at 37 ◦C and pH 7.4. In a first ppro ch, the adsorption kinetic of
J. Funct. Biomater. 2019, 10, 18 8 of 19
BSA on m-CPPD crystals was plotted by following the evolution of BSA quantity adsorbed (Qads) as a
function of time (Figure 4) with initial concentration of BSA fixed to 0.5 g/L. The results show that Qads
increased quickly with time and a plateau was reached within the first 30 min. The contact time for the
adsorption experiments was then fixed to 30 min to limit the evolution and potential dissolution of
m-CPPD crystals during the adsorption test.
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Figure 4. Kinetic of BSA adsorption on m-CPPD crystals at 37 ◦C and pH 7.4. The initial BSA
concentration was fixed to 0.5 g/L.
In a second step, the adsorption experiments of BSA on m-CPPD crystals were performed using
the selected contact time with initial BSA concentration varying from 0 to 10 g/L. The remained
concentration of BSA in the supernatant after adsorption was titrated by UV spectroscopy. Figure 5
showed the adsorption isotherm obtained by plotting the evolution of the amount of BSA adsorbed
onto m-CPPD from dilute solutions (Qads in µmol·m−2) as a function of its remaining equilibrium
concentration in solution (Ceq in mmol·L−1). Small quantity of albumin adsorbed onto m-CPPD crystals
was observed compared with the adsorption data of proteins or others biomolecules on inorganic
crystal surfaces like calcium phosphates [34–36]. These results showed that BSA/m-CPPD crystals
interactions remained quite low.
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Figure 5. Isotherm of BSA adsorption on m-CPPD crystals (n = 3) at 37 ◦C and pH 7.4. The dashed red
curve indicates curve-fitting with the Langmuir-Freundlich model (r2 = 0.97).
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To understand the adsorption behavior, mathematical analysis was applied to model the adsorption
isotherm of BSA onto m-CPPD crystals. Although fitting to the Langmuir isotherm model leads
to an acceptable r2 coefficient (0.96), the isotherm did not reach a plateau and the quantity of BSA
molecules adsorbed was low. While the model of Freundlich leads to poor correspondence (r2 = 0.93),
the Langmuir-Freundlich model best described the present data (r2 = 0.97) as seen in Figure 5 [43]. This
model is generally encountered when the adsorbed molecules present low affinity for mineral surfaces
(low interaction adsorbate/surface and low quantity adsorbed). The adsorption parameters N, K and n
can be calculated from the Langmuir-Freundlich equation (also known as Sip’s equation), Equation (1):
Qads = N ×
(
K ×Ceq
)n
1 +
(
K ×Ceq
)n (1)
where N is the maximum adsorption coverage (µmol·m−2), K the affinity constant of adsorption
(L·mmol−1) and n the constant of heterogeneity. Applying this model, the values obtained for the
adsorption parameters of BSA/m-CPPD isotherm are: N = 0.031 ± 0.005 µmol·m−2, K = 0.04 ± 0.02
L·mmol−1 and n = 1.4± 0.3. The parameters of adsorption N and K determined were very low compared
with adsorption parameters of biomolecules or drugs adsorbed on apatitic calcium phosphates for
example [34–36]. These values reflected the small quantity of adsorbed BSA and the low affinity
of BSA for m-CPPD surface. The small amount adsorbed could also be related to the size (steric
dimension) and conformation of BSA macromolecules on crystal surface. Moreover, n parameter value
appeared greater than 1 suggesting the existence of a high affinity of the adsorbed molecules with
each other. Often molecules could form multilayers onto mineral surface, i.e., some are adsorbed on
already adsorbed molecules, or at least could induce agglomeration of adsorbed particles of CPPD.
This behavior has been recently described for the adsorption of some drug molecules onto calcium
phosphate compounds also described by Sips model [36,44].
Analysis of phosphorus and calcium concentrations in solution after adsorption experiment using
ICP OES spectrometer were plotted as a function of the quantity of BSA adsorbed (Figure A3). The
Ca and P amounts were not affected by BSA adsorption: they remained low and stable during the
adsorption, mainly related to m-CPPD dissolution equilibrium. Ions in solution do not participate
to the adsorption process contrary to Langmuir adsorption of biomolecules observed onto mineral
surface like calcium phosphates [45]. The mechanism of adsorption of BSA on m-CPPD crystals cannot
be described by an ion exchange process between BSA and ionic species on the surface of m-CPPD
crystals during adsorption. In accordance with the Sips model proposed, the adsorption of BSA onto
m-CPPD crystals is related to a weak interaction protein/crystals.
To better understand the mechanism of adsorption, we also characterized the solid after adsorption
experiments. FTIR spectroscopy and XRD analyzes (Figures A1 and A2) showed that no other crystalline
phase or change in crystallinity or detection of the presence of any other groups occurred. No change
in crystal size and morphology of m-CPPD crystals was observed by SEM after adsorption of BSA
(Figure 6a,b). However the SEM images evidenced a high agglomeration of the crystals after BSA
adsorption. The observation of such crystals agglomeration was in accordance with the Sips model
of adsorption proposed and possible interactions between BSA molecules. This agglomeration of
m-CPPD crystals were observed after in vitro cell tests (Figure 6c), and could be responsible for the
decrease of the inflammatory response.
Atomic force microscopy (AFM) measurements have been performed to determine the interaction
force between CPP and proteins and elucidate at the atomic level the adhesive properties of BSA
protein on m-CPPD crystals. A method of AFM technique using chemical functionalization of AFM tips
has been used to measure the adhesion forces between BSA and m-CPPD crystals. Preliminary tests
highlighted the difficulty to obtain single crystals of m-CPPD. However preliminary results (Figure 7)
show the sensitivity of the method that can distinguish between m-CPPD crystal and glass. m-CPPD
highest adhesion peak is at 1.2 nN while that of glass is at 1.9 nN. This might indicate that BSA has
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much less affinity to m-CPPD than to glass for which it is known to have a good affinity. These results
are in agreement with the parameters of the Langmuir-Freundlich model we determined, indicating a
small quantity of adsorbed BSA and a low affinity of BSA for m-CPPD crystal surface.
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3. Discussion
In this study we confirmed that protein adsorption altered the inflammatory properties of m-CPPD
crystals. We showed that protein coating on MSU and m-CPPD crystals decreased the potential of
these crystals to induce IL-1β production, the main cytokine that drove crystal-induced inflammation,
by macrophages which were the cells that initiated the crystal inflammation process [46]. Our results
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suggested that protein coating decreased MSU and m-CPPD crystal-induced IL-1β production through
NLRP3 inflammasome inhibition. Indeed, we observed that crystal-induced ATP production and
mitochondrial membrane depolarization which were two known NLRP3 activators were modulated
by protein coating [47]. As previously reported, the effects of protein coating on crystal-induced cell
responses might be secondary to modulations of crystal/cell interactions [13,30–33,48–55]. In favor of
this hypothesis was that the inhibiting coating effects disappeared when cells were stimulated during
15 min with uncoated crystals. These modifications of crystal/cell membrane interactions might also
disturb NLRP3 inflammasome activation as reported by Ng et al. [41]. These latter authors showed that
MSU crystals directly interacted with cell membrane leading to cell-membrane cholesterol and lipid
sorting and Syk kinase and NLRP3 activation [41]. Similarly, Hari et al. observed that MSU and silica
crystal-induced NLRP3 activation was independent of crystal phagocytosis but relied on crystal/cell
membrane interaction leading to potassium eﬄux [40]. The interactions between crystals and cell
membranes involved several mechanisms including electrostatic bindings between the negatively
charged (zeta potential) crystal surfaces and cell-surface components, hydrogen or ion bindings and
protein adsorption on crystal surfaces [13,19,21–29,32,33,37,48–54]. Interestingly, several authors had
shown, first, that the inflammatory potential of MSU and m-CPPD crystals varied according to proteins
coated on the crystal surfaces, and second, that the coated-proteins changed during inflammation
states [13,19,21–29,32,33,37,48–54]. Thus, the inflammatory potential of MSU crystals increased with
IgG coating while it decreased with ApoE or LDL coating [25–29,37]. Similarly, inflammation-induced
by CPPD crystals was increased with IgG, plasma, serum or heparin coating but decreased with HDL
or LDL coating [13,32,33]. Our results were in agreement with these former data and added new
insights on the inhibition effects of BSA and serum coating on MSU and m-CPPD crystal-induced
cell activation. Moreover, we identified using proteomic technology more than 30 proteins coated
on m-CPPD crystal surface, most of them have never been described such as hemoglobin, ApO,
complement and coagulation factors. Altogether, these findings gave new insights into pathogenesis of
crystal-related rheumatic diseases and subsequently new therapeutic approaches. Thus, as described
with nanoparticle-protein corona, crystal-protein interactions could be considered as a biological
entity which interacted with immune cells in a biological system, hence influencing cell responses,
macrophage uptake and fate and inflammatory responses [31,55]. Understanding the biological identity
of crystal-protein complex, how it forms, changes and evolves in different clinical conditions, tissue
environment and factors and how it modulates the immune response is necessary and vital to improve
crystal-related disease care.
As albumin was present in high amount on m-CPPD crystal surface, we performed a physico-
chemical study of BSA adsorption as protein model on m-CPPD crystals to elucidate the mechanism
of protein/CPPD interaction and biological investigation results. Few studies had focused on
CPPD/proteins interactions from a physico-chemical point of view, to our knowledge only Winternitz
studied the adsorption of IgG protein on m-CPPD synthetic crystals and described the isotherms
obtained by Freundlich equation which has traditionally been used to describe heterogeneous
binding [56]. In the present paper, the mechanism of adsorption of BSA onto m-CPPD surface
was well described by a Langmuir-Freundlich isotherm based on low quantity of proteins adsorbed and
weak protein/m-CPPD crystal interaction in agreement with the low affinity of CPPD and MSU crystals
with albumin already reported in the literature and also with the low adhesion forces between BSA
and a m-CPPD crystal we measured by AFM [21,22]. We showed that the affinity of BSA for m-CPPD
crystals was low whereas BSA was one of the proteins with the highest mascot score we determined by
proteomic analysis. This apparent paradoxical result might be related to the strong interaction between
protein molecules each other’s that seemed to occur. Indeed, these interactions between BSA molecules
adsorbed on each m-CPPD crystals could explain crystals agglomeration observed by microscopy
after in vitro cell tests and adsorption test (Figure 6). Whether the agglomeration state of the m-CPPD
crystals could contribute to regulate the inflammatory response needs further investigations.
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Such physico-chemical approach had never been reported in the literature to study CPPD
crystals-proteins interactions. This physico-chemical study of BSA adsorption on m-CPPD crystals
surface gave interesting results which could be extended to the other type of calcium pyrophosphate
dihydrate clinically relevant (t-CPPD) and the precursor phases of CPPD (a-CPP and m-CPPTβ). Now
the model of adsorption have to be confirmed on these other types of hydrated calcium pyrophosphate
crystals and the influence of several parameters such as experimental conditions like the pH, the size and
the agglomeration state of the crystals or the nature of the proteins have to be considered; particularly
BSA was used as model of albumin protein but such approach can applied to the use of human serum
albumin or other proteins of interest as hemoglobin, fibrinogen, complement and coagulation factors
identified by proteomic analysis.
In conclusion protein adsorption on m-CPPD crystal surface might interfere on crystal/cell
membrane interactions and modulated positively or negatively crystal-induced inflammation. The
model of adsorption isotherm we determined, Langmuir-Freundlich isotherm, is in agreement with
such hypothesis. Low amount of BSA is adsorbed on m-CPPD crystals with a weak BSA/m-CPPD
crystal interaction but strong interaction between protein molecules each other’s favoring crystal
agglomeration that might lower the inflammatory properties of m-CPPD crystals. Further investigations
of these interactions could help to understand why CPPD deposit has so many clinical features.
4. Materials and Methods
4.1. MSU and m-CPPD Crystals Synthesis and Characterization
MSU crystals were obtained by spontaneous precipitation of uric acid in NaOH solution (0.01 M)
at 60 ◦C as described [18]. m-CPPD pure phase was synthesized and characterized using a published
protocol and methods [57]. The as-prepared m-CPPD powder was characterized by X-ray diffraction
(Inel Equinox 1000 diffractometer with Co Kα radiation, Artenay, France), FTIR spectroscopy (Thermo
Nicolet 5700 Fourier-transform infrared spectrometer, transmission mode with m-CPPD powder in KBr
pellet) and scanning electron microscopy (SEM, Leo 435 VP microscope, Zeiss, Oberkochen, Germany,
m-CPPD powder silver-plated before observation). Chemical analysis of pyrophosphate and calcium
was performed as follows: standard spectrophotometric (Shimadzu UV1800 spectrometer, λ = 460 nm,
Canby, OR, USA) determination of the yellow phosphovanadomolybdic acid complex was used to
determine phosphate concentration after hydrolysis of the pyrophosphate (at 100 ◦C in acidic medium
during 1 h) into phosphate ions; calcium concentration was determined by complexometry with
ethylenediaminetetraacetic acid (EDTA). The specific surface area of the m-CPPD was evaluated using
the Brunauer–Emmett–Teller method (nitrogen adsorption on a Monosorb Nova 1000, Quantachrome
Instruments, Boynton Beach, FL, USA). This thorough physicochemical characterization of the
synthetic calcium pyrophosphate dihydrate powder showed that it consists of a pure m-CPPD crystals
(Figures A1 and A2) [57].
Crystals/particles were dispersed by brief sonication and suspended at 2 mg/mL in phosphate
buffered saline (PBS). They were prepared under endotoxin-free conditions and tested negative with
Pierce Limulus amebocyte Assay (Thermo Fisher Scientific).
4.2. Mice
Adult Sv129 mice were used for in vivo experiments. Wild-type (wt) mice were purchased from
Janvier Lab (Le Genest-St-Isle, France). Mice were maintained in cages (max. 6/cage) in a facility with
12 h light/dark cycles. Mice were fed diets ad libitum. All experiments were approved by the national
ethical committee (#65352016110314184795V3).
4.3. Cells Culture
For in vitro experiments, bone marrow cells were recovered from tibia and femoral bones of mice
and seeded in 24-well plates at 2 × 106 cells/mL in L929-conditioned RPMI1640 media as described [43].
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Every 2 days, cells were washed and the media renewed until complete differentiation of BMDMs.
BMDMs were maintained in RPMI1640 supplemented with 10% fetal bovine serum (FBS), HEPES (25
mM), L-glutamine (2 mM), penicillin (100 U/mL), and streptomycin (100 µg/mL) and were primed
overnight with ultrapure lipopolysaccharide (LPS; 20 ng/mL, Invivogene, San Diego, CA, USA).
Human monocytic leukemia (THP-1) cells were maintained in the same complete RPMI1640
media and were primed for 6 h with phorbol 12-myristate 13-acetate (PMA, 0.5 µM, Sigma-Aldrich,
Saint-Louis, MO, USA), washed with PBS1X, then plated in 24-well dishes at 3 × 105 cells/wells and
left overnight in complete media.
Primed BMDMs and THP-1 cells were washed twice with PBS and stimulated at the indicated times
with the synthetic MSU or m-CPPD crystals (200 µg/mL) in FBS-free media. For some experiments,
crystals were incubated with FBS, 35% bovine serum albumin (BSA, Sigma Aldrich, Saint-Louis,
MO, USA), mouse serum or blood lysate 30 min before stimulation then washed twice in PBS and
resuspended at 2 mg/mL. After a 6 h (2 h for ATP dosage) crystal stimulation, supernatant was collected
for cytokine quantification and cells were lyzed for mRNA quantification. Mouse blood was obtained
by cardiac puncture, then blood was centrifuged 5 min at 4000 rpm at 4 ◦C, the supernatant was
collected as serum and the pellet was lyzed to obtain blood cell lysate.
4.4. Cytokines and ATP Quantification
Cytokines and ATP production in supernatants were measured respectively by using IL-1β ELISA
kits (Invitrogen, Carlsbad, California, USA) and ATP determination kit (Molecular probes, Eugene,
OR, USA).
4.5. mRNA Quantification
Primed THP-1 cells were lyzed with TRizol reagent (Invitrogen), 6 h after crystal stimulation, and
total RNA was extracted by using the ISOLATE II RNA kit (Bioline, London, UK). First, 500 ng of
total RNA were reverse transcripted to cDNA using the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystem, Foster City, California, USA) (LifeECO Thermal Cycler, Bioer Technology,
Hangzhou, Binjiang, China). Then, quantitative PCR was performed with 25 ng of cDNA using
the SensiFAST SYBR No-ROX Kit (Bioline, London, UK) for 40 cycles (95 ◦C for 5 s, 60 ◦C for 30 s)
(LightCycler®480 Instrument, Roche Life Science, Penzberg, Germany). Sequences of primers for
qPCR are reported in Table 2.
Table 2. List of primers.
Forward Reverse
IL-1β TTCGAGGCACAAGGCACAA TGGCTGCTTCAGACACTTGAG
IL-8 GAGCCAGGAAGAAACCACCG TGGCAAAACTGCACCTTCACA
TNF-α CCCATGTTGTAGCAAACCCTC TATCTCTCAGCTCCACGCCA
Cox-2 GCTGTTCCCACCCATGTCAA AAATTCCGGTGTTGAGCAGT
GAPDH AGCCACATCGCCAGACAC GCCCAATACGACCAAATCC
4.6. Flow Cytometry
THP1 cells were plated in 24-wells dishes at 3 × 105 cells/well, washed twice in PBS and stimulated
with the synthetic MSU or m-CPPD crystals (200 µg/mL) in FBS-free media for 30 min then washed
twice in PBS and incubated for 30 min in JC-1 (Molecular probes) then cells were washed twice in PBS
and analyzed with the BD FACS Canto II cytometer (BD Bioscience, Franklin Lakes, NJ, USA). Data
were analyzed with BDFACS Diva software (BD Bioscience, Franklin Lakes, NJ, USA).
4.7. Proteomic Analysis
m-CPPD crystals were incubated for 30 min in FBS at 37 ◦C then washed twice with FBS and
finally crystals were collected by centrifugation. Proteins adsorbed on microcrystals were processed
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for mass spectrometry analysis without specific elution step. They were reduced with 10 mM DTT,
alkylated with 55 mM iodoacetamide (IAA) and incubated with 20 µL of 25 mM NH4HCO3 containing
12.5 µg/mL sequencing-grade trypsin (Promega, Madison, WI, USA) overnight at 37 ◦C. Digests were
pooled according to each samples and analyzed by a LTQ Velos Orbitrap (Thermo Fisher Scientific, San
Jose, CA, USA) coupled to an Easy nano-LC Proxeon 1000 system (Thermo Fisher Scientific, San Jose,
CA, USA). Chromatographic separation of peptides was performed with the following parameters:
Acclaim Pepmap100 pre-column (5 mm, 300 µmi.d., C18, 5 µm, 100 Å) and column Easy Column
Proxeon C18 (50 cm, 75 µm i.d., 120 Å), 300 nL/min flow, gradient rising from 95% solvent A (water,
0.1% formic acid) to 35% B (100% acetonitrile, 0.1% formic acid) in 97 min, then to 80% B in 6 min for
a total run time of 118 min. Peptides were analyzed in the Orbitrap cell in full ion scan mode at a
resolution of 30,000 (at m/z 400) and a mass range of 400–1800 m/z. Fragments were obtained with a
collision-induced dissociation (CID) activation with a collisional energy of 40%, an activation Q of 0.25
for 10 ms, and analyzed in the LTQ. MS/MS data were acquired in a data dependent mode in which 20
most intense precursor ions were isolated, with a dynamic exclusion of 20 seconds and an exclusion
mass width of 10 ppm.
For the protein identification step, all MS and MS/MS data were processed with the Mascot
search engine (Matrix Science, version 2.5.1, London, UK). The mass tolerance was set to 7 ppm for
precursor ions and 0.5 Da for fragments. The following modifications were used in variable parameters:
oxidation (M), phosphorylation (Ser, Thr, Tyr), carbamidomethylation (Cys), deamidation (Asn, Gln),
acetylation (N-term, Lys). The maximum number of missed cleavages was limited to 2 for trypsin
digestion. The UniProt Bos taurus protein database was used for the identification step. Peptides with
a Mascot score above 15 were considered.
4.8. Statistical Analysis
Data are reported as mean ± SEM. After verification of Gaussian distribution and homogeneous
variance of each group, multiple t test followed by false discovery rate (FDR) correction were used to
compare experimental conditions. Otherwise, Kruskal-Wallis test with FDR correction was chosen. The
significance level was set at P < 0.05. GraphPad Prism 7.0 (San Diego, CA, USA) was used for analysis.
4.9. BSA Adsorption on m-CPPD Crystals
m-CPPD synthetic crystals (100 mg) have been dispersed in adsorption medium (5 mL), an aqueous
isotonic solution (NaCl 0.15 M) of bovine serum albumin (BSA, Sigma Aldrich ref. A7030, Saint-Louis,
MO, USA) at different concentrations (from 0 to 10 g/L, pH = 7.4, in triplicate). Blanks containing
the adsorption solution without crystals were used as controls. The suspensions obtained have been
sonicated (2 min) and incubated at 37 ◦C during 30 min without stirring to reach adsorption equilibrium,
and then centrifuged (10 min, 5000 tr/min). The supernatants have been then filtered onto Millipore
membrane (pore size 0.2 µm) and store before analysis. The solids (powders) have been washed and
dried at 37 ◦C and then characterized.
Phosphorus and calcium contents in solution were determined using an inductively coupled
plasma atomic emission spectrometer (ICP-OES, Thermo Electron, Iris Intrepid II XLD, Waltham, MA,
USA), and BSA concentration by UV spectrophotometry (Shimadzu UV 1800 spectrometer, Canby, OR,
USA) at 278 nm.
4.10. Preliminary Study of m-CPPD-BSA Interaction Force by Atomic Force Microscopy
Sample preparation: A drop of Epoxy glue (Loctite EA3430, Henkel Corp., Bridgewater, NJ,
USA) was first spin coated (20 s at 800 rpm followed by 2 min at 6000 rpm) on a cleaned glass slide.
The sample was then left to dry 50 min at 60 ◦C. A 200 µL drop of m-CPPD suspended crystals in
de-ionized water (1.33 g/L) was then spin coated (20 s at 200 rpm followed by 30 s at 6000 rpm) on the
epoxy glass slide and left to dry 15 min at 37 ◦C.
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AFM tip functionalization with BSA: We used an AFM tip functionalization protocol reported by
Jauvert et al. [58]. Briefly, this protocol makes use of dendrimer functionalized tips presenting CHO
terminal functions that can react to link NH2 groups of proteins covalently. MLCT (Bruker, Karlsruhe,
Germany) cantilever (nominal spring constant of 0.01 N/m) was used. The functionalized tip was then
made to react with BSA proteins (Sigma Aldrich, Saint-Louis, MO, USA) prepared in solution (0.5 g/L
in 0.1 M carbonate buffer at pH = 8.4).
AFM data acquisition: All measurements were performed in PBS 1X buffer solution (Sigma Aldrich,
Saint-Louis, MO, USA) at 37 ◦C using a Bioscope Catalyst AFM (Bruker, Bruker, Karlsruhe, Germany).
AFM cantilever sensitivity was calibrated on glass in PBS 1x buffer at 37 ◦C and its spring constant was
determined using the thermal noise method [59]. First a rough (20 µm)2 32 × 32 force volume mode
image was performed on an isolated m-CPPD crystal (Figure 7A) allowing a more precise (1.2 µm)2
128 × 128 force volume mode image on the top of the crystal to be acquired (Figure 7B). Data was
acquired in triplicate on the top of three different crystals and on glass. The adhesion force data was
extracted using Nanoscope Analysis 1.5 software (Bruker, Bruker, Karlsruhe, Germany) and plotted
into a histogram (Figure 7C) using R open source statistical software.
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(mM) in solution as a function of BSA quantity (Qads) adsorbed (mM) on m-CPPD crystals (n = 3). 
Very low amounts of P and Ca were released in solution after adsorption: measured concentrations 
were close to the detection limit of the inductively coupled plasma-atomic emission spectroscopy 
(ICP-OES) spectrometer. 
References 
1. Ryu, K.; Iriuchishima, T.; Oshida, M.; Kato, Y.; Saito, A.; Imada, M.; Aizawa, S.; Tokuhashi, Y.; Ryu, J. The 
prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint. 
Osteoarthr. Cartil. 2014, 22, 975–979. 
2. Richette, P.; Bardin, T.; Doherty, M. An update on the epidemiology of calcium pyrophosphate dihydrate 
crystal deposition disease. Rheumatology 2009, 48, 711–715. 
3. Kuo, C. F.; Grainge, M. J.; Zhang, W.; Doherty, M. Global epidemiology of gout: prevalence, incidence and 
risk factors. Nat. Rev. Rheumatol. 2015, 11, 649–662. 
4. Slater, C.; Laurencin, D.; Burnell, V.; Smith, M.E.; Grover, L.M.; Hriljac, J.A.; Wright, A.J. Enhanced stability 
and local structure in biologically relevant amorphous materials containing pyrophosphate. J. Mater. Chem. 
2011, 21, 18783. 
5. Zunić, B.-; Christoffersen, M.R.; Christoffersen, J. Structure of the beta form of calcium pyrophosphate 
tetrahydrate. N.a. Crystallogr. Sect. B Struct. Sci. 2000, 56, 953–958. 
6. Gras P. Etude physico-chimique et structurale de pyrophosphates de calcium hydratés: application aux 
micro-calcifications associées à l’arthrose. Ph.D. Thesis, INP Toulouse, Toulouse, France, 2014. (In French) 
7. Narayan, S.; Kolly, L.; Bagnoud, N.; Chobaz, V.; Roger, T.; So, A.; Busso, N.; Pazár, B.; Ea, H.-K.; Lioté, F. 
Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1β Secretion through the NLRP3 
Inflammasome In Vitro. J. Immunol. 2011, 186, 2495–2502.  
8. Martinon, F.; Pétrilli, V.; Mayor, A.; Tardivel, A.; Tschopp, J.; P, V. Gout-associated uric acid crystals 
activate the NALP3 inflammasome. Nat. Cell Boil. 2006, 440, 237–241. 
9. Zhang, W.; Doherty, M.; Bardin, T.; Barskova, V.; Guerne, P.-A.; Jansen, T.L.; Leeb, B.F.; Perez-Ruiz, F.; 
Pimentao, J.; Punzi, L.; et al. European League Against Rheumatism recommendations for calcium 
pyrophosphate deposition. Part I: terminology and diagnosis. Ann. Rheum. Dis. 2011, 70, 563–570. 
10. Lebre, F.; Sridharan, R.; Sawkins, M.J.; Kelly, D.J.; O’Brien, F.J.; Lavelle, E.C. The shape and size of 
hydroxyapatite particles dictate inflammatory responses following implantation. Sci. Rep. 2017, 7, 2922.  
11. Cheung, H.S.; Devine, T.R.; Hubbard, W. Calcium phosphate particle induction of metalloproteinase and 
mitogenesis: effect of particle sizes. Osteoarthr. Cartil. 1997, 5, 145–151.  
12. Nadra, I.; Boccaccini, A.R.; Philippidis, P.; Whelan, L.C.; McCarthy, G.M.; Haskard, D.O.; Landis, R.C. 
Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by 
macrophages. Atherosclerosis 2008, 196, 98–105.  
13. Burt, H.M.; Jackson, J.K.; Rowell, J. Calcium pyrophosphate and monosodium urate crystal interactions 
with neutrophils: effect of crystal size and lipoprotein binding to crystals. J. Rheumatol. 1989, 16, 809–817.  
0 1 2 3
0
1x10-1
2x10-1
3x10-1
4x10-1
5x10-1
[C
a] 
or
 [P
] (
mM
)
Qads (mM)
Figure A3. Concentration of Ca (open red circles o) and P (solid black squares ) content released
(mM) in solution as a function of BSA quantity (Qads) adsorbed (mM) on m-CPPD crystals (n = 3).
Very low amounts of P and Ca were released in solution after adsorption: measured concentrations
were close to the detection limit of the inductively coupled plasma-atomic emission spectroscopy
(ICP-OES) spectrometer.
References
1. Ryu, K.; Iriuchishima, T.; Oshida, M.; Kato, Y.; Saito, A.; Imada, M.; Aizawa, S.; Tokuhashi, Y.; Ryu, J. The
prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint.
Osteoarthr. Cartil. 2014, 22, 975–979. [CrossRef]
2. Richette, P.; Bardin, T.; Doherty, M. An update on the epidemiology of calcium pyrophosphate dihydrate
crystal deposition disease. Rheumatology 2009, 48, 711–715. [CrossRef]
3. Kuo, C.F.; Grainge, M.J.; Zhang, W.; Doherty, M. Global epidemiology of gout: Prevalence, incidence and
risk factors. Nat. Rev. Rheumatol. 2015, 11, 649–662. [CrossRef] [PubMed]
4. Slater, C.; Laurencin, D.; Burnell, V.; Smith, M.E.; Grover, L.M.; Hriljac, J.A.; Wright, A.J. Enhanced stability
and local structure in biologically relevant amorphous materials containing pyrophosphate. J. Mater. Chem.
2011, 21, 18783. [CrossRef]
5. Zunic´, B.-; Christoffersen, M.R.; Christoffersen, J. Structure of the beta form of calcium pyrophosphate
tetrahydrate. Acta Crystallogr. Sect. B Struct. Sci. 2000, 56, 953–958. [CrossRef]
J. Funct. Biomater. 2019, 10, 18 17 of 19
6. Gras, P. Etude physico-chimique et structurale de pyrophosphates de calcium hydratés: Application aux
micro-calcifications associées à l’arthrose. Ph.D. Thesis, INP Toulouse, Toulouse, France, 2014. (In French).
7. Narayan, S.; Kolly, L.; Bagnoud, N.; Chobaz, V.; Roger, T.; So, A.; Busso, N.; Pazár, B.; Ea, H.-K.; Lioté, F.
Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1β Secretion through the NLRP3
Inflammasome In Vitro. J. Immunol. 2011, 186, 2495–2502.
8. Martinon, F.; Pétrilli, V.; Mayor, A.; Tardivel, A.; Tschopp, J.; P, V. Gout-associated uric acid crystals activate
the NALP3 inflammasome. Nat. Cell Boil. 2006, 440, 237–241. [CrossRef]
9. Zhang, W.; Doherty, M.; Bardin, T.; Barskova, V.; Guerne, P.-A.; Jansen, T.L.; Leeb, B.F.; Perez-Ruiz, F.;
Pimentao, J.; Punzi, L.; et al. European League Against Rheumatism recommendations for calcium pyrophosphate
deposition. Part I: Terminology and diagnosis. Ann. Rheum. Dis. 2011, 70, 563–570. [CrossRef]
10. Lebre, F.; Sridharan, R.; Sawkins, M.J.; Kelly, D.J.; O’Brien, F.J.; Lavelle, E.C. The shape and size of
hydroxyapatite particles dictate inflammatory responses following implantation. Sci. Rep. 2017, 7, 2922.
[CrossRef]
11. Cheung, H.S.; Devine, T.R.; Hubbard, W. Calcium phosphate particle induction of metalloproteinase and
mitogenesis: Effect of particle sizes. Osteoarthr. Cartil. 1997, 5, 145–151. [CrossRef]
12. Nadra, I.; Boccaccini, A.R.; Philippidis, P.; Whelan, L.C.; McCarthy, G.M.; Haskard, D.O.; Landis, R.C. Effect
of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages.
Atherosclerosis 2008, 196, 98–105. [CrossRef]
13. Burt, H.M.; Jackson, J.K.; Rowell, J. Calcium pyrophosphate and monosodium urate crystal interactions with
neutrophils: Effect of crystal size and lipoprotein binding to crystals. J. Rheumatol. 1989, 16, 809–817.
14. Watanabe, W.; Baker, D.G.; Schumacher, H.R. Comparison of the acute inflammation induced by calcium
pyrophosphate dihydrate, apatite and mixed crystals in the rat air pouch model of a synovial space.
J. Rheumatol. 1992, 19, 1453–1457.
15. Liu-Bryan, R.; Pritzker, K.; Firestein, G.S.; Terkeltaub, R. TLR2 Signaling in Chondrocytes Drives Calcium
Pyrophosphate Dihydrate and Monosodium Urate Crystal-Induced Nitric Oxide Generation. J. Immunol.
2005, 174, 5016–5023. [CrossRef]
16. Cheung, H.S.; Halverson, P.B.; Mccarty, D.J. Release of Collagenase, Neutral Protease, and Prostaglandins
from Cultured Mammalian Synovial Cells by Hydroxyapatite and Calcium Pyrophosphate Dihydrate
Crystals. Arthritis Rheum. 1981, 24, 1338–1344. [CrossRef]
17. Campillo-Gimenez, L.; Renaudin, F.; Jalabert, M.; Gras, P.; Gosset, M.; Rey, C.; Sarda, S.; Collet, C.;
Cohen-Solal, M.; Combes, C.; et al. Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate
Relies on NF-κB Activation and MAPK Pathways. Front. Immunol. 2018, 9. [CrossRef]
18. Lioté, F.; Prudhommeaux, F.; Schiltz, C.; Champy, R.; Herbelin, A.; Bardin, T.; Ortiz-Bravo, E. Inhibition and
prevention of monosodium urate monohydrate crystal–induced acute inflammation in vivo by transforming
growth factor β1. Arthritis Rheum. 1996, 39, 1192–1198. [CrossRef]
19. Roch-Arveiller, M.; Legros, R.; Chanaud, B.; Muntaner, O.; Strzalko, S.; Thuret, A.; Willoughby, D.; Giroud, J.
Inflammatory reactions induced by various calcium pyrophosphate crystals. Biomed. Pharmacother. 1990, 44,
467–474. [CrossRef]
20. Swan, A.; Heywood, B.; Chapman, B.; Seward, H.; Dieppe, P. Evidence for a causal relationship between
the structure, size, and load of calcium pyrophosphate dihydrate crystals, and attacks of pseudogout. Ann.
Rheum. Dis. 1995, 54, 825–830. [CrossRef]
21. Kozin, F.; Mccarty, D.J. Protein adsorption to monosodium urate, calcium pyrophosphate dihydrate, and
silica crystals. Relationship to the pathogenesis of crystal-induced inflammation. Arthritis Rheum. 1976, 19,
433–438. [CrossRef]
22. Kozin, F.; McCarty, D.J. Protein binding to monosodium urate monohydrate, calcium pyrophosphate
dihydrate, and silicon dioxide crystals. I. Physical characteristics. J. Lab. Clin. Med. 1977, 89, 1314–1325.
23. Terkeltaub, R.; Martin, J.; Curtiss, L.K.; Ginsberg, M.H. Apolipoprotein B mediates the capacity of low density
lipoprotein to suppress neutrophil stimulation by particulates. J. Boil. Chem. 1986, 261, 15662–15667.
24. Abramson, S.; Hoffstein, S.T.; Weissmann, G. Superoxide anion generation by human neutrophils exposed
to monosodium urate. effect of protein adsorption and complement activation. Arthritis Rheum. 1982, 25,
174–180. [CrossRef]
25. Scanu, A.; Luisetto, R.; Oliviero, F.; Gruaz, L.; Sfriso, P.; Burger, D.; Punzi, L. High-density lipoproteins inhibit
urate crystal-induced inflammation in mice. Ann. Rheum. Dis. 2015, 74, 587–594. [CrossRef]
J. Funct. Biomater. 2019, 10, 18 18 of 19
26. Rosen, M.S.; Baker, D.G.; Schumacher, H.R.; Cherian, P.V. Products of polymorphonuclear cell injury
inhibit IgG enhancement of monosodium urate-induced superoxide production. Arthritis Rheum. 1986, 29,
1473–1479. [CrossRef]
27. Sieck, M.S.; Schumacher, H.R.; Ortiz-Bravo, E. Changes in the proteins coating monosodium urate crystals
during active and subsiding inflammation. immunogold studies of synovial fluid from patients with gout
and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum. 1993, 36, 1274–1285.
28. Ortiz-Bravo, E.; Schumacher, H.R. Components generated locally as well as serum alter the phlogistic effect
of monosodium urate crystals in vivo. J. Rheumatol. 1993, 20, 1162–1166.
29. Terkeltaub, R.; Curtiss, L.K.; Tenner, A.J.; Ginsberg, M.H. Lipoproteins containing apoprotein B are a major
regulator of neutrophil responses to monosodium urate crystals. J. Clin. Investig. 1984, 73, 1719–1730.
[CrossRef]
30. Barbero, F.; Russo, L.; Vitali, M.; Piella, J.; Salvo, I.; Borrajo, M.L.; Busquets-Fité, M.; Grandori, R.; Bastús, N.G.;
Casals, E.; et al. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune
System. Semin. Immunol. 2017, 34, 52–60. [CrossRef]
31. Xiao, W.; Gao, H. The impact of protein corona on the behavior and targeting capability of nanoparticle-based
delivery system. Int. J. Pharm. 2018, 552, 328–339. [CrossRef]
32. Burt, H.M.; Jackson, J.K. Enhancement of crystal induced neutrophil responses by opsonisation of calcium
pyrophosphate dihydrate crystals. Ann. Rheum. Dis. 1993, 52, 599–607. [CrossRef]
33. Winternitz, C.I.; Jackson, J.K.; Burt, H.M. The interaction of monoclinic calcium pyrophosphate dihydrate
crystals with neutrophils. Rheumatol. Int. 1996, 16, 101–107. [CrossRef]
34. Benaziz, L.; Barroug, A.; Legrouri, A.; Rey, C.; Lebugle, A. Adsorption of O-Phospho-L-Serine and L-Serine
onto Poorly Crystalline Apatite. J. Colloid Interface Sci. 2001, 238, 48–53. [CrossRef]
35. Rey, C.; Combes, C.; Drouet, C.; Cazalbou, S.; Grossin, D.; Brouillet, F.; Sarda, S. Surface properties of
biomimetic nanocrystalline apatites; applications in biomaterials. Prog. Cryst. Growth Charact. Mater. 2014,
60, 63–73. [CrossRef]
36. Sarda, S.; Errassifi, F.; Marsan, O.; Geffre, A.; Trumel, C.; Drouet, C. Adsorption of tranexamic acid on
hydroxyapatite: Toward the development of biomaterials with local hemostatic activity. Mater. Sci. Eng. C
2016, 66, 1–7. [CrossRef]
37. Piccini, A.; Carta, S.; Tassi, S.; Lasiglié, D.; Fossati, G.; Rubartelli, A. ATP is released by monocytes stimulated
with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way. Proc. Natl.
Acad. Sci. USA 2008, 105, 8067–8072. [CrossRef]
38. Zhou, R.; Yazdi, A.S.; Menu, P.; Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nat.
Cell Boil. 2011, 475, 122. [CrossRef]
39. Smiley, S.T.; Reers, M.; Mottola-Hartshorn, C.; Lin, M.; Chen, A.; Smith, T.W.; Steele, G.D.; Chen, L.B.
Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming
lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA 1991, 88, 3671–3675. [CrossRef]
40. Hari, A.; Zhang, Y.; Tu, Z.; Detampel, P.; Stenner, M.; Ganguly, A.; Shi, Y. Activation of NLRP3 inflammasome
by crystalline structures via cell surface contact. Sci. Rep. 2014, 4, 7281. [CrossRef]
41. Ng, G.; Sharma, K.; Ward, S.M.; Desrosiers, M.D.; Stephens, L.A.; Schoel, W.M.; Li, T.; Lowell, C.A.; Ling, C.-C.;
Amrein, M.W.; et al. Receptor-independent, direct membrane binding leads to cell surface lipid sorting and
Syk kinase activation in dendritic cells. Immunity 2008, 29, 807–818. [CrossRef]
42. Burt, H.M.; Jackson, J.K.; Wu, W. Crystal-induced inflammation: Studies of the mechanism of
crystal-membrane interactions. Scanning Microsc. 1991, 5, 273.
43. Foo, K.Y.; Hameed, B. Insights into the modeling of adsorption isotherm systems. Chem. Eng. J. 2010, 156,
2–10. [CrossRef]
44. Pascaud, P.; Montesi, M.; Drouet, C.; Sarda, S.; Iafisco, M.; Adamiano, A.; Panseri, S.; Tampieri, A.
Superparamagnetic iron-doped nanocrystalline apatite as a delivery system for doxorubicin. J. Mater.
Chem. B 2016, 4, 57–70.
45. Pascaud, P.; Errassifi, F.; Brouillet, F.; Sarda, S.; Barroug, A.; Legrouri, A.; Rey, C. Adsorption on apatitic
calcium phosphates for drug delivery: Interaction with bisphosphonate molecules. J. Mater. Sci. Mater. Med.
2014, 25, 2373–2381. [CrossRef] [PubMed]
J. Funct. Biomater. 2019, 10, 18 19 of 19
46. Martin, W.J.; Walton, M.; Harper, J. Resident macrophages initiating and driving inflammation in a
monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum.
2009, 60, 281–289. [CrossRef] [PubMed]
47. Latz, E.; Duewell, P. NLRP3 inflammasome activation in inflammaging. Semin. Immunol. 2018, 40, 61–73.
[CrossRef] [PubMed]
48. Terkeltaub, R.; Tenner, A.J.; Kozin, F.; Ginsberg, M.H. Plasma Protein Binding by Monosodium Urate Crystals.
Arthritis Rheum. 1983, 26, 775–783. [CrossRef]
49. Terkeltaub, R.A.; Dyer, C.A.; Martin, J.; Curtiss, L.K. Apolipoprotein (apo) E inhibits the capacity
of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticularapo E and
demonstration of apo E binding to urate crystals in vivo. J. Clin. Investig. 1991, 87, 20–26. [CrossRef]
50. Jackson, J.K.; Tudan, C.; Sahl, B.; Pelech, S.L.; Burt, H.M. Calcium pyrophosphate dihydrate crystals activate
MAP kinase in human neutrophils: Inhibition of MAP kinase, oxidase activation and degranulation responses
of neutrophils by taxol. Immunology 1997, 90, 502–510. [CrossRef]
51. Nguyen, C.; Lieberherr, M.; Bordat, C.; Velard, F.; Côme, D.; Liote, F.; Ea, H.-K. Intracellular calcium oscillations
in articular chondrocytes induced by basic calcium phosphate crystals lead to cartilage degradation. Osteoarthr.
Cartil. 2012, 20, 1399–1408. [CrossRef]
52. Burt, H.M.; Jackson, J.K. Characterization and membranolytic effects of triclinic calcium pyrophosphate
dihydrate crystals. J. Rheumatol. 1987, 14, 968–973.
53. Burt, H.M.; Jackson, J.K. Cytosolic Ca2+ concentration determinations in neutrophils stimulated by
monosodium urate and calcium pyrophosphate crystals: Effect of protein adsorption. J. Rheumatol. 1994, 21,
138–144.
54. Wallingford, W.R.; Mccarty, D.J. Differential Membranolytic Effects of Microcrystalline Sodium Urate and
Calcium Pyrophosphate Dihydrate. J. Exp. Med. 1971, 133, 100–112. [CrossRef]
55. Charbgoo, F.; Nejabat, M.; Abnous, K.; Soltani, F.; Taghdisi, S.M.; Alibolandi, M.; Shier, W.T.; Steele, T.W.;
Ramezani, M. Gold nanoparticle should understand protein corona for being a clinical nanomaterial.
J. Control. Release 2018, 272, 39–53. [CrossRef]
56. Winternitz, C.I. Calcium pyrophosphate dihydrate crystal deposition disease: Characterization and IgG
binding properties of monoclinic calcium pyrophosphate dihydrate crystals. Ph.D. Thesis, University of
British Columbia, Vancouver, BC, Canada, 1994.
57. Gras, P.; Rey, C.; Marsan, O.; Sarda, S.; Combes, C. Synthesis and Characterisation of Hydrated Calcium
Pyrophosphate Phases of Biological Interest. Eur. J. Inorg. Chem. 2013, 2013, 5886–5895. [CrossRef]
58. Jauvert, E.; Dague, E.; Séverac, M.; Ressier, L.; Caminade, A.-M.; Majoral, J.-P.; Trevisiol, E. Probing single
molecule interactions by AFM using bio-functionalized dendritips. Sens. Actuators B Chem. 2012, 168,
436–441. [CrossRef]
59. Hutter, J.L.; Bechhoefer, J. Calibration of atomic-force microscope tips. Sci. Instrum. 1993, 64, 1868–1873.
[CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
